Literature DB >> 1707433

Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls.

B H Breier1, B W Gallaher, P D Gluckman.   

Abstract

This report describes essential requirements for the validation of a radioimmunoassay (RIA) for insulin-like growth factor-I (IGF-I) and presents solutions to some problems and pitfalls commonly observed. The preparation of IGF-I to be used as radioligand or standard has to be selected carefully since some IGF-I preparations are contaminated with variants which demonstrate different potencies for different antisera used in the RIA. Accurate assessment of IGF-I levels in blood plasma requires an efficient extraction method for the IGF-binding proteins (IGFBPs). Extraction methods to remove the influence of IGFBPs in the RIA were compared using blood plasma of considerable differences in IGF-I/IGFBP ratios. Acidification of plasma before column chromatography on Sephadex G-75 (G75) is generally considered to be the most reliable extraction method, but it is very time-consuming. The acid-ethanol extraction (AE) of plasma is not valid in many situations. Non-parallel displacement to the IGF-I standard was observed with AE-extracted plasma samples in the RIA. In addition, a comparison of IGF-I values obtained in the RIA after AE or G75 extraction of fetal ovine plasma has shown no significant correlation. We report an extraction technique based on a modified AE extraction followed by cryo-precipitation (AEC). AEC extraction on blood plasma reduced residual IGFBPs to a level that did not interfere in the assay. Furthermore, AEC-extracted plasma samples showed parallel displacement in the RIA to highly purified preparations of authentic IGF-I. We observed high correlations, with a slope close to unity, of IGF-I values obtained in the RIA using the AEC or G75 extraction for plasma from different species including adult and fetal sheep, rat, mouse and man. The AEC extraction provides a rapid and simple alternative to G75 extraction for blood plasma from a variety of species provided that high-affinity antisera are used for the RIA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707433     DOI: 10.1677/joe.0.1280347

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  43 in total

1.  Loss of the pregnancy-induced rise in cortisol concentrations in the ewe impairs the fetal insulin-like growth factor axis.

Authors:  Ellen C Jensen; Laura Bennet; Charles Wood; Mark Vickers; Bernhard Breier; Alistair J Gunn; Maureen Keller-Wood
Journal:  Reprod Fertil Dev       Date:  2011       Impact factor: 2.311

2.  Immunodiscrimination between native and recombinant somatotropin: a possible pathway?

Authors:  A Guidi; G Iannone; L Castigliego; D Gianfaldoni
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

3.  Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment.

Authors:  A Torsello; G Rossoni; V Locatelli; V De Gennaro Colonna; M Bernareggi; M Francolini; E E Müller; F Berti
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

4.  Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

Authors:  H Kiaris; A V Schally; J L Varga; K Groot; P Armatis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Differential effect of insulin-like growth factor-1 and growth hormone on hypothalamic regulation of growth hormone secretion in the rat.

Authors:  I Gil Ad; A Weizman; A Silbergeld; Z Dickerman; B Kaplan; Z Laron; Y Koch
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

6.  Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.

Authors:  M Brink; J Wellen; P Delafontaine
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

7.  A murine model for human sepiapterin-reductase deficiency.

Authors:  Seungkyoung Yang; Young Jae Lee; Jin-Man Kim; Sean Park; Joanna Peris; Philip Laipis; Young Shik Park; Jae Hoon Chung; S Paul Oh
Journal:  Am J Hum Genet       Date:  2006-01-31       Impact factor: 11.025

8.  The circulating molecular weight forms of infused recombinant insulin-like growth factor-I and effects on glucose and fat metabolism in lambs.

Authors:  R G Douglas; B H Breier; B W Gallaher; J B Koea; J H Shaw; P D Gluckman
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

9.  Gender and age in the biochemical assessment of cure of acromegaly.

Authors:  P U Freda; R E Landman; R E Sundeen; K D Post
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

10.  Prenatal expression of growth hormone receptor/binding protein and insulin-like growth factor-I (IGF-I) in the enamel organ. Role for growth hormone and IGF-I in cellular differentiation during early tooth formation?

Authors:  B K Joseph; N W Savage; W G Young; M J Waters
Journal:  Anat Embryol (Berl)       Date:  1994-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.